期刊文献+

重症肌无力患者胸腺Fas基因突变及氨基酸变异分析 被引量:1

Study on Fas gene mutation and amino acid variation in thymus tissue of patients with myasthenia gravis
下载PDF
导出
摘要 目的 :分析重症肌无力 (MG)患者胸腺Fas基因突变及其编码蛋白质的氨基酸变异 ,探讨Fas分子在重症肌无力发生中的作用。方法 :提取 8例MG患者胸腺总RNA ,经RT PCR法扩增出Fas基因全长 ,克隆后用荧光标记法进行基因测序 ,用DNASIS、OMIGA软件与Genbank中Fas序列进行同源性比较和分析。结果 :8例患者胸腺组织 6例出现Fas基因突变 ,突变率为 75 % (6 /8) ,其中 5例发生 2个以上位点突变 ,只有 1个位点突变的 1例 (1 2 .5 % ,1 /8) ;突变类型为 1 6 4位A→G ,相应的氨基酸变异为 5 5位Asp→Gly,96位His Arg,1 92位Arg→Lys和 2 5 1位Lys→Arg。Fas基因高度保守 ,患者之间同源性为 99.6 %~ 1 0 0 % ,Fas分子同源性为 98.7%~ 99.7%。结论 :重症肌无力患者胸腺组织中存在Fas基因突变和Fas分子结构变异 。 Aim: To study the functions of Fas molecule in myasthenia gravis by investigating whether Fas gene mutation and Fas molecule variation occur in thymus tissue of MG patients.Methods: The total RNA from thymus MG patients were extracted.The cDNA of Fas gene were amplified by reverse transcription polymerase chain reaction(RT PCR),the product was cloned into T Vectors and sequenced.DNASIS and OMIGA software were used for sequencing and homogenous analysis.Results: Most of MG patients thymus tissue had Fas gene mutation,and the mutation rate was 75%(6/8).Multi sites mutation rate was 62.5%(5/8).There were 4 point mutation forms:A→G at 164nt, A→G at 287nt, G→A at 575nt, and A→G at 752nt.Conclusion: Fas gene mutation exists in thymus tissues of MG patients.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2004年第4期572-575,共4页 Journal of Zhengzhou University(Medical Sciences)
基金 国家自然科学基金资助项目 3 9970 2 64 河南省 2 0 0 2年度杰出青年项目
关键词 重症肌无力 FAS基因 突变 同源性 myasthenia gravis(MG) Fas gene gene mutation sequence analysis
  • 相关文献

参考文献14

  • 1Kishimoto H,Sprent J.The thymus and central tolerance.Clin immunol,2000,95(1 Pt 2):S3
  • 2Deng CS , Goluszko E and Christadoss P. Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance.J Immunol, 2001, 166(5):3 458
  • 3Wu JM,Wu B,Miagkov et al.Specific immunotherapy of experimental myasthenia gravis in vitro:the ''guided missile''strategy.Cell Immunol, 2001,208(2):137
  • 4Krammer PH,Dhein J,Walacxak H,et al.The role of APO-1 mediated apoptosis in immune system.Immunol Rev,1994,142:175
  • 5Moulian N, Bidault J, Truffault F, et al.Thymocyte Fas Expression Is Dysregulated in Myasthenia Gravis Patients With Anti-Acetylcholine Receptor Antibody. Blood, 1997,89(9):3 287
  • 6Rieux-Laucat F, Deist FL,Hivroz C, et al.Mutation in Fas associated with human lymphoproliferative syndrome and autoimmunity.Science,1995,268(5 215):1 347
  • 7Fisher GH,Rosenberg FJ,Straus SE et al.Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.Cell,1995,81(6):935
  • 8Booker JK,Reap EA,Cohen PL.Expression and function of Fas on cells damaged by γ-irradiation in B6 and B6/Lpr mice.J Immunol,1998,161(9):4 536
  • 9杜英,张清勇,阮丽荣,梁长春,李倩如,何炜.重症肌无力患者胸腺细胞凋亡障碍与Fas表达异常的关系[J].细胞与分子免疫学杂志,2003,19(5):450-453. 被引量:7
  • 10孙保东,沈南,裴军,陈顺乐,王元,钱捷.系统性红斑狼疮凋亡相关基因Fas sFas mRNA表达研究[J].中华风湿病学杂志,2000,4(1):7-10. 被引量:8

二级参考文献25

  • 1鲍卫汉,王传民,朱洪荫.瘢痕疙瘩不同部位组织形态学研究[J].中华整形烧伤外科杂志,1995,11(5):368-370. 被引量:17
  • 2Ju SF, Panka DJ, Cui H, et al. Fas(CD95)/FasL interaction required for programmed cell death after T-cell activa6on[J].Nature, 1995,373(6 513) :444 - 448.
  • 3Ogasawara J, Suda T, Nagata S. Selective apoptosis of CD4^+ CD8^+ thymocytes by the anti-Fas antibody[J]. J Exp Med,1995,181(2) :485 - 496.
  • 4Hershberger PA, He HL, Mccarthy SA, et al. In vitro thymocyte maturation is associated with reduced cellular susceptibility to Fas-mediated apoptosis[ J]. Cellular Immunol, 1998,185(2) : 134 - 145.
  • 5Moulian N, Bidault J, Truffault F, et al. Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody [ J ]. Blood 1997,89 (9) :3 287 - 3 295.
  • 6Fisher GH, Rosenberg FJ, Straus SE, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome[J]. Cell, 1995,81 (16) :935 - 946.
  • 7Weker H. The thymus in myasthenia gravis [ J]. Ann NY Acad Sci, 1993,681(3) :47 - 53.
  • 8Oeturka A, Behrmann I, Falk W, et al. Purification and molecular cloning of the APO- 1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily.Sequence identity with the Fas antigen [ J]. J Biol Chem,1992,267(15) : 10 709 - 10 715.
  • 9Huang Q R,Mole Immuno,1997年,34卷,8/9期,577页
  • 10Tian Q,J Experiment Med,1995年,182卷,865页

共引文献42

同被引文献9

  • 1Ciafaloni E, Sanders DB. Advances in myasthenia gravis.Curr Neurol Neurosci Rep,2002,2 ( 1 ) :89.
  • 2Shiono H, Fujii Y, Okumura M,et al. Failure to down regulate Bcl-2 protein in thymic germinal center B cell in myasthenia gravis. Eur J Immunol, 1997.27(4) :805.
  • 3Onodera J, Nakamura S, Nagano I, et al. Upregulation of Bcl-2 protein in the myasthenic thymus. Ann Neurol, 1996,39(4) :521.
  • 4Moulian N. Bidault J, Truffault F, et al. Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody. Blood, 1997,89 ( 9 ) :3 287.
  • 5Levinson AI, Zheng Y, Caulton G , et aL Intrathymic expression of neuromuscular acetylcholine receptor and the immunpathgenesis of myasthenia gravis. Immunol Res.2003.27 ( 2-3 ) : 399.
  • 6Garcia YR. Pothitakis JC, Krolick KA. Myocyte production of nitric oxide in respone to AChR-reactive antibodies in two inbred rat strains may influence disease outcome in experimental myasthenia gravis, Clin Immunol, 2003,106 ( 2 ) : 116.
  • 7Drachman DB, Myasthenia gravis. N Engl J Med, 1994,330(25) -1 797.
  • 8武勇琴,吕传真,周天华,杨茹,乔健,马兰,裴钢.应用差别显示聚合酶链反应筛选及鉴定重症肌无力相关基因[J].中华神经科杂志,1998,31(2):69-71. 被引量:14
  • 9周志刚,武勇琴,任惠民,吕传真.重症肌无力差异片段P10在人肌肉和胸腺组织中的表达[J].中华神经科杂志,2000,33(1):20-22. 被引量:5

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部